These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 22737648)

  • 21. Botulinum toxin and pregnancy.
    de Oliveira Monteiro E
    Skinmed; 2006; 5(6):308. PubMed ID: 17086003
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of two botulinum toxin type A preparations for treating crow's feet: a split-face, double-blind, proof-of-concept study.
    Prager W; Wissmüller E; Kollhorst B; Williams S; Zschocke I
    Dermatol Surg; 2010 Dec; 36 Suppl 4():2155-60. PubMed ID: 21134046
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A case of dysphagia following botulinum toxin injection for neck rejuvenation.
    Phothong W; Wanitphakdeedecha R; Keskool P; Manuskiatti W
    J Cosmet Dermatol; 2017 Mar; 16(1):15-17. PubMed ID: 27637174
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Double vision due to lateral rectus injury after cosmetic botulinum toxin injections.
    Khan S; Pathak G; Milgraum D; Tamhankar M; Milgraum S
    Australas J Dermatol; 2023 Aug; 64(3):e220-e223. PubMed ID: 37386928
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Application of botulinum toxin in Horner's muscle for the treatment of dry eye.
    Diaz AL; Chaparro TA; Tello A; Coy H; Frederick GA; Parra MM
    Arch Soc Esp Oftalmol (Engl Ed); 2018 Dec; 93(12):617-620. PubMed ID: 30001848
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Botulinum toxin injection: a review of injection principles and protocols.
    Rapp DE; Lucioni A; Bales GT
    Int Braz J Urol; 2007; 33(2):132-41. PubMed ID: 17488531
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Muscle paralysis produced by botulinum toxin type A injection in treated torticollis patients compared with toxin naive individuals.
    Sloop RR; Cole D; Patel MC
    Mov Disord; 2001 Jan; 16(1):100-5. PubMed ID: 11215566
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ocular surface status in patients with hemifacial spasm under long-lasting treatment with botulinum A toxin: A comparative fellow eye study.
    Pellegrini M; Schiavi C; Taroni L; Sebastiani S; Bernabei F; Roda M; Moscardelli F; Giannaccare G
    Indian J Ophthalmol; 2019 Sep; 67(9):1405-1409. PubMed ID: 31436182
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adverse events after botulinum A toxin injection for neurogenic voiding disorders.
    De Laet K; Wyndaele JJ
    Spinal Cord; 2005 Jul; 43(7):397-9. PubMed ID: 15741978
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Botulinum toxin A treatment in patients suffering from blepharospasm and dry eye.
    Horwath-Winter J; Bergloeff J; Floegel I; Haller-Schober EM; Schmut O
    Br J Ophthalmol; 2003 Jan; 87(1):54-6. PubMed ID: 12488263
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Botulinum-A toxin treatment of the lower eyelid improves infraorbital rhytides and widens the eye.
    Flynn TC; Carruthers JA; Carruthers JA
    Dermatol Surg; 2001 Aug; 27(8):703-8. PubMed ID: 11493292
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Botulinum toxin injection and tear production.
    Alsuhaibani AH; Eid SA
    Curr Opin Ophthalmol; 2018 Sep; 29(5):428-433. PubMed ID: 29994851
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of lidocaine injection, botulinum toxin injection, and dry needling to trigger points in myofascial pain syndrome.
    Kamanli A; Kaya A; Ardicoglu O; Ozgocmen S; Zengin FO; Bayik Y
    Rheumatol Int; 2005 Oct; 25(8):604-11. PubMed ID: 15372199
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Management of upper eyelid retraction associated with dysthyroid orbitopathy during the acute inflammatory phase with botulinum toxin type A].
    Nava Castañeda A; Tovilla Canales JL; Garnica Hayashi L; Velasco Y Levy A
    J Fr Ophtalmol; 2017 Apr; 40(4):279-284. PubMed ID: 28336282
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Botulinum toxin type a and its uses in dry eye disease.
    Victoria AC; Pino A
    Plast Reconstr Surg; 2012 Jul; 130(1):209e-210e. PubMed ID: 22743932
    [No Abstract]   [Full Text] [Related]  

  • 36. A randomized, double-masked, crossover comparison of the efficacy and safety of botulinum toxin type A produced from the original bulk toxin source and current bulk toxin source for the treatment of cervical dystonia.
    Naumann M; Yakovleff A; Durif F;
    J Neurol; 2002 Jan; 249(1):57-63. PubMed ID: 11954869
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of preseptal and pretarsal injections of botulinum toxin in the treatment of blepharospasm and hemifacial spasm.
    Cakmur R; Ozturk V; Uzunel F; Donmez B; Idiman F
    J Neurol; 2002 Jan; 249(1):64-8. PubMed ID: 11954870
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vein imaging laser reduces bruising in bruise-prone botulinum toxin injected patients.
    Lowe NJ; Halliday D
    J Cosmet Laser Ther; 2016 Jun; 18(3):162-4. PubMed ID: 27031120
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Myasthenia gravis exacerbation with low dose ocular botulinum toxin for epiphoria.
    Watts J; Brew B; Tisch S
    J Clin Neurosci; 2015 Dec; 22(12):1979-81. PubMed ID: 26188667
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term treatment of blepharospasm with botulinum toxin A: a service-based study over a 16-year follow-up in southern China.
    Fang XB; Xie MS; Song ZB; Zhong ZG; Wang Y; Ou ZL; Dang C; Li L; Zhang WX
    Neurol Sci; 2020 Mar; 41(3):645-652. PubMed ID: 31745757
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.